Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026
Go back to Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026| (NASDAQ: FENC) | Delayed: 10.70 -0.08 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.78 | 52 Week High | $ | |||
| Open | $10.78 | 52 Week Low | $ | |||
| Day High | $10.88 | P/E | N/A | |||
| Day Low | $10.60 | EPS | $ | |||
| Volume | 48,339 | |||||
| Forest Laboratories (NYSE: FRX) | Delayed: 12.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.00 | 52 Week High | $100.88 | |||
| Open | $24.87 | 52 Week Low | $64.33 | |||
| Day High | $12.00 | P/E | 20.69 | |||
| Day Low | $12.00 | EPS | $0.58 | |||
| Volume | 20 | |||||
